Ni Li
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research 26
- Cancer, Lipids, and Metabolism 18
- MicroRNA in disease regulation 16
- Oncology top 0.5%
- Global Cancer Incidence and Screening 34
- Colorectal Cancer Screening and Detection 33
- Cancer Risks and Factors 24
- Epidemiology top 0.5%
- Cervical Cancer and HPV Research 31
- Molecular Biology top 1%
- Microbiology top 1%
-
- Gastric Cancer Management and Outcomes 18
- Co-authors
- Wanqing ChenHongda ChenYiwen YuWei CaoGary M. CliffordSilvia FranceschiRebecca Howell‐JonesPeter J.F. Snijders
- Cited by
- Cancer ResearchOncologyEpidemiology
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Ni Li
355 papers receiving 11.3k citations
Hit Papers
Peers
Comparison fields: 5 of 187
- Cancer Research 1.9k
- Oncology 2.7k
- Epidemiology 2.7k
- Molecular Biology 4.2k
- Microbiology 375
Countries citing papers authored by Ni Li
This map shows the geographic impact of Ni Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ni Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ni Li more than expected).
Fields of papers citing papers by Ni Li
This network shows the impact of papers produced by Ni Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ni Li. The network helps show where Ni Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ni Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 9 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 0 | |
| 12 | 2023 | 0 | |
| 13 | 2023 | 25 | |
| 14 | 2023 | 5 | |
| 15 | 2022 | 51 | |
| 16 | 2022 | 24 | |
| 17 | 2022 | 27 | |
| 18 | 2022 | 2 | |
| 19 | 2018 | 213 | |
| 20 | 2007 | 21 |
About Ni Li
Ni Li is a scholar working on Oncology, Cancer Research, Epidemiology, Molecular Biology and Structural Biology, having authored 389 papers that have together received 11.4k indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (34 papers), Colorectal Cancer Screening and Detection (33 papers), Cervical Cancer and HPV Research (31 papers), Cancer-related molecular mechanisms research (26 papers), Cancer Risks and Factors (24 papers), Cancer, Lipids, and Metabolism (18 papers), Gastric Cancer Management and Outcomes (18 papers) and MicroRNA in disease regulation (16 papers). The work is most often cited by research in Cancer Research (1.9k citations), Oncology (2.7k citations), Epidemiology (2.7k citations), Molecular Biology (4.2k citations) and Microbiology (375 citations). Ni Li has collaborated with scholars based in China, United States and France. Frequent co-authors include Wanqing Chen, Hongda Chen, Yiwen Yu, Wei Cao, Gary M. Clifford, Silvia Franceschi, Rebecca Howell‐Jones, Peter J.F. Snijders, Min Dai and Peng Guan. Their work appears in journals such as Cancer Medicine, Oncotarget, Frontiers in Oncology, Scientific Reports and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.